Life-saving drugs now cheaper
ELEVEN breakthrough medicines used to treat life-threatening health conditions such as diabetes, cancer, arthritis and asthma have been made cheaper.
From April 1, a federal subsidy though the Pharmaceutical Benefits Scheme (PBS) means patients can save thousands on previously expensive medications.
Research shows access to prescribed medicine decreases the further people live from a major city.
The Federal Government said it hoped the impact of the PBS would be felt in rural and remote communities through improving access to life-saving drugs.
For drugs scheduled under the PBS, the maximum price of a script will be capped at $39.50, with concessional patients paying $6.40.
Newly added listings, such as the lung cancer treatment Atezolizumab, were recommended by the independent Pharmaceutical Benefits Advisory Committee.
Before its PBS inclusion, a course of Atezolizumab cost $99,104, but the treatment will now cost $6.40 for pensioners or a maximum of $39.50 per script.